Cargando…

Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study

We aimed to evaluate the efficacy (short-term changes in surrogates of decongestion) and safety following the ambulatory administration of subcutaneous furosemide (SCF) in patients with WHF. Fifty-five ambulatory patients were treated with SCF administered by an elastomeric pump for at least 72 h. S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Civera, Jose, de la Espriella, Rafael, Heredia, Raquel, Miñana, Gema, Santas, Enrique, Conesa, Adriana, Mollar, Anna, Sastre, Clara, Martínez, Ana, Villaescusa, Amparo, Núñez, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213343/ https://www.ncbi.nlm.nih.gov/pubmed/34642870 http://dx.doi.org/10.1007/s12265-021-10173-1

Ejemplares similares

Venous Leg Compression for Tissue Decongestion in Patients With Worsening Congestive Heart Failure
por: Civera, Jose, et al.
Publicado: (2022)

Incidence, Treatment and Clinical Impact of Iron Deficiency in Chronic Heart Failure: A Longitudinal Analysis
por: Miñana, Gema, et al.
Publicado: (2022)

Sex‐Related Differences in Mortality Following Admission for Acute Heart Failure Across the Left Ventricular Ejection Fraction Spectrum
por: Santas, Enrique, et al.
Publicado: (2021)

Right Ventricular Dysfunction Staging System for Mortality Risk Stratification in Heart Failure with Preserved Ejection Fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Beta‐blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve‐HR trial)
por: Palau, Patricia, et al.
Publicado: (2020)

Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
por: Miñana, Gema, et al.
Publicado: (2022)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Long-Term Prognostic Value of Cognitive Impairment on Top of Frailty in Older Adults after Acute Coronary Syndrome
por: Sanchis, Juan, et al.
Publicado: (2021)

Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study
por: Núñez, Julio, et al.
Publicado: (2016)

Furosemide infusion in children with dengue fever and hypoxemia
por: Bharath Kumar Reddy, K. R., et al.
Publicado: (2014)

Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes
por: de la Espriella, Rafael, et al.
Publicado: (2020)

Frailty Tools for Assessment of Long-term Prognosis After Acute Coronary Syndrome
por: Sanchis, Juan, et al.
Publicado: (2020)

Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure
por: Bertomeu‐Gonzalez, Vicente, et al.
Publicado: (2020)

Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness
por: de la Espriella‐Juan, Rafael, et al.
Publicado: (2018)

Dermatologic adverse effect of subcutaneous furosemide administration in a cat
por: Mazzoldi, Chiara, et al.
Publicado: (2023)

Heart Failure with Preserved Ejection Fraction: An Urgent Need for Precision Medicine
por: Miñana, Gema, et al.
Publicado: (2021)

Effect of continuous furosemide infusion on outcome of acute kidney injury
por: Ni, Jie, et al.
Publicado: (2019)

A Fast and Validated HPLC Method for Simultaneous Determination of Dopamine, Dobutamine, Phentolamine, Furosemide, and Aminophylline in Infusion Samples and Injection Formulations
por: Chen, Fuchao, et al.
Publicado: (2021)

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion
por: Dahiya, Garima, et al.
Publicado: (2022)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
por: Dalal, Lena, et al.
Publicado: (2021)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
por: Ruponen, Marika, et al.
Publicado: (2021)

Peritoneal and Urinary Sodium Removal in Refractory Congestive Heart Failure Patients Included in an Ambulatory Peritoneal Dialysis Program: Valuable for Monitoring the Course of the Disease
por: Miñana, Gema, et al.
Publicado: (2023)

FORMULATION OF FUROSEMIDE SOLID DISPERSION WITH MICRO CRYSTALLINE CELLULOSE FOR ACHIEVE RAPID DISSOLUTION
por: Patel, Rajanikant C., et al.
Publicado: (2010)

Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
por: Sombié, Charles Bavouma, et al.
Publicado: (2022)

Prognostic Value of the Interaction between Galectin-3 and Antigen Carbohydrate 125 in Acute Heart Failure
por: Núñez, Julio, et al.
Publicado: (2015)

Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure
por: Paterna, Salvatore, et al.
Publicado: (2015)

Short‐Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial‐IRON Trial
por: del Canto, Irene, et al.
Publicado: (2022)

On the Subcutaneous Injection of Blood, Infusion (Subcutaneous) and Intravenous Transfusion
por: Oehler,, et al.
Publicado: (1888)

Clinical Predictors and Prognosis of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) without ST-Segment Elevation in Older Adults
por: Gabaldon-Perez, Ana, et al.
Publicado: (2023)

Homocysteine and long-term recurrent infarction following an acute coronary syndrome
por: Miñana, Gema, et al.
Publicado: (2021)

Goal-directed diuresis: A case — control study of continuous furosemide infusion in critically ill trauma patients
por: Yeh, Daniel Dante, et al.
Publicado: (2015)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction
por: Amiguet, Martina, et al.
Publicado: (2023)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Development and Characterization of Eudragit(®)-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
por: Vlachou, Marilena, et al.
Publicado: (2019)

An NMR crystallography investigation of furosemide
por: Zilka, Miri, et al.
Publicado: (2018)

Furosemide: No effect: case report
Publicado: (2020)

Use of Oral Furosemide in Hemodialysis
por: Siga, Esteban, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rtofres65v9co41ojc0gqvu9p7